These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13870300)

  • 1. [A new neuroleptic with delayed hypnogenic effect: dipiperon (R3345), butyrophenone carbamide].
    BOBON J; COLLARD J; DEMARET A
    Acta Neurol Psychiatr Belg; 1961 Jul; 61():611-30. PubMed ID: 13870300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic utilization in clinical EEG of a neuroleptic butyrophenone: MD-2028].
    MORIN G; BOUCHACOURT A; VIGNOT P; COULONJOU R
    Presse Med (1893); 1961 Apr; 69():915-6. PubMed ID: 13772666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Note on the trial use of fluoromethoxyphenylpiperazine-butyrophenone (28-28 M.D.) at the time of admission].
    DAUMEZON G; AUDISIO M; CONTE C; HUGUET P
    Ann Med Psychol (Paris); 1960 Mar; 118(1)():539-41. PubMed ID: 13814224
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 5. [Place of a new neuroleptic, Dominal, in neuropsychiatric therapy].
    COUSIN JP
    Sem Hop Ther Paris; 1961 Jun; 37():544-6. PubMed ID: 13881803
    [No Abstract]   [Full Text] [Related]  

  • 6. [The neuroleptic effects of the piperazine derivative of butyrophenone (MD-2028)].
    CHAUCHARD P; MAZOUE H
    C R Seances Soc Biol Fil; 1961; 155():29-31. PubMed ID: 24545495
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a new neuroleptic, R 2028 or haloanisone].
    DE RYCK A
    Acta Neurol Psychiatr Belg; 1962 Jun; 62():589-603. PubMed ID: 14026044
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of a new fluorinated phenothiazine neuroleptic, fluphenazine.
    TAYLOR IJ
    Dis Nerv Syst; 1960 Mar; 21():169-72. PubMed ID: 13837156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thigridazine. Neuroleptic drug derived from phenothiazine].
    RISER M; GAYRAL L; STERN H; TURNIN J
    Presse Med (1893); 1960 Apr; 68():679-80. PubMed ID: 14437552
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of a neuroleptic agent of the butyrophenone series (2028 MD) in clinical E.E.G].
    MORIN G; VIGNOT P; BOUCHACOURT A
    Rev Neurol (Paris); 1960 Sep; 103():272-5. PubMed ID: 13772670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psycho-pharmacological study of a 5th butyrophenone: "methylperidide", a neuroleptic pyrrolidinamide and methyl derivative of haloperidol].
    DIVRY P; BOBON J; COLLARD J; DEMARET A
    Acta Neurol Psychiatr Belg; 1960 Dec; 60():1073-86. PubMed ID: 13723131
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychopharmacology of a third neuroleptic from the butyrophenone series: R 2498 or triperidol].
    DIVRY P; BOBON J; COLLARD J; DEMARET A
    Acta Neurol Psychiatr Belg; 1960 May; 60():465-80. PubMed ID: 13816974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Supporting therapy with neuroleptic preparations in conditions of a psychoneurological clinic].
    KANEVSKAIA FO; TARASOV GK; TSUTSUL'KOVSKAIA MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():242-7. PubMed ID: 14404299
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorophenothiazine-238A, a new and more potent neuroleptic agent.
    ROBINSON J; McCABE ES; YEE R
    Del State Med J; 1960 Oct; 32():388-92. PubMed ID: 13742300
    [No Abstract]   [Full Text] [Related]  

  • 15. [A NEW MAJOR NEUROLEPTIC AGENT: TRIPERIDOL. 1ST CLINICAL RESULTS OBTAINED WITH A NEW BUTYROPHENONE DERIVATIVE].
    DUBOIS C; DICK P; REY-BELLET J
    Schweiz Med Wochenschr; 1963 Nov; 93():1600-4. PubMed ID: 14153115
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON THE PROBLEM OF THE RELEVANCE OF THE CHARACTERISTIC ACTION OF NEUROLEPTIC SUBSTANCES TO CLINICAL RESULTS. PSYCHOMETRIC STUDIES WITH DIPIPERON].
    HEINRICH K; RUMPF K
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:587-90. PubMed ID: 14253974
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the clinical use in neuropsychiatry of 3-ethyl-10-(2-methyl-3-dimethylaminopropyl)-phenothiazine HCl (RP-6484), new phenothiazine neuroleptic].
    RONDEPIERRE JJ; ROPERT R; AZOULAY J
    Presse Med (1893); 1962 Jun; 70():1342-4. PubMed ID: 14493669
    [No Abstract]   [Full Text] [Related]  

  • 18. Librium, a new non-sedative neuroleptic drug: a clinical evaluation.
    ENGLISH DC
    Curr Ther Res Clin Exp; 1960 Mar; 2():88-91. PubMed ID: 13820396
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of neuroleptic medication in psychotherapeutic interaction.
    SARWER-FONER GJ
    Compr Psychiatry; 1960 Oct; 1():291-300. PubMed ID: 13746631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial in clinical neuropsychiatry of a thiophenylpridylamine derivative: prothipendyl HCl or Dominal, new neuroleptic].
    MOUREN P; SERRATRICE G; SOULAYROL RG; ARDITTI M
    Sem Hop Ther Paris; 1961 Nov; 37():845-9. PubMed ID: 14476692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.